Decreased fasting free fatty acids with l-carnitine in children with carnitine deficiency

At the time of acute presentation, children with carnitine deficiency may have increased free fatty acid concentrations and hypoglycemia. However, whether carnitine replacement affects the plasma concentration of these substrates remains to be determined. Therefore, to evaluate the effect of carnitine replacement on plasma substrate and hormone concentrations, five children with carnitine deficiency (two idiopathic, two secondary to long-chain acyl coenzyme A dehydrogenase deficiency, one secondary to isovaleric acidemia) were fasted overnight before and after treatment with oral carnitine (80 ± 7 mg.kg^-1.day^-1). During carnitine supplementation, plasma total carnitine (19 ± 4 versus 45 ± 6 nmol/ml, pretreatment versus treatment, respectively) and free carnitine (11 ± 3 versus 31 ± 6 nmol/ml), as well as red blood cell total carnitine (0.057 ± 0.019 versus 0.130 ± 0.019 nmol/mg of hemoglobin) increased (p < 0.05). Fasting plasma glucose (83 ± 4 versus 85 ± 3 mg/dl) and ketone body (0.54 ± 0.18 and 0.56 ± 0.20 mM) concentrations did not change with carnitine supplementation, but plasma free fatty acids (1.28 ± 0.32 versus 0.77 ± 0.07 mM) decreased (p < 0.05). No differences in fasting insulin, growth hormone, or Cortisol concentrations were observed. Urinary excretion of free carnitine (0.1 ± 0.0 versus 2.4 ± 0.7 ^mol/mg creatinine), total carnitine (0.3 ± 0.1 versus 3.4 ± 0.9 /µmol/mg creatinine) and acyl carnitine (0.2 ± 0.1 versus 0.9 ± 0.3 µmol/ mg creatinine) increased (p < 0.05) with carnitine supplementation. The decreased plasma free fatty acid concentrations with carnitine supplementation may be due to more efficient fatty acid oxidation and/or increased urinary excretion of fatty acids as acylcarnitines.